180 Life Sciences
Chas Bountra is a professor of Translational Medicine at the Nuffield Dept. of Medicine, Director of the Centre for Medicines Discovery and Pro Vice Chancellor for Innovation at the University of Oxford. Chas Bountra was previously Head of Biology at GlaxoSmithKline.
This person is not in the org chart
This person is not in any offices
180 Life Sciences
180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University.